CN Patent

CN103168032A — 抑制间变性淋巴瘤激酶的苯并咪唑和氮杂苯并咪唑化合物

Assigned to Amgen Inc · Expires 2013-06-19 · 13y expired

What this patent protects

式（I）的化合物是间变性淋巴瘤激酶的有用的抑制剂。式（I）的化合物具有下面的结构，其中，变量的定义在说明书中提供。

USPTO Abstract

式（I）的化合物是间变性淋巴瘤激酶的有用的抑制剂。式（I）的化合物具有下面的结构，其中，变量的定义在说明书中提供。

Drugs covered by this patent

Patent Metadata

Patent number
CN103168032A
Jurisdiction
CN
Classification
—
Expires
2013-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Amgen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.